Evidence supporting the use of: Adrenergic amines
For the health condition: Narcolepsy

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Adrenergic amines, particularly those with stimulant properties such as amphetamines and their derivatives, have a well-established scientific basis for the treatment of narcolepsy. Narcolepsy is a neurological disorder characterized by excessive daytime sleepiness, cataplexy, and disrupted nighttime sleep. The primary pathophysiology involves dysfunction in the regulation of sleep-wake cycles, often due to hypocretin deficiency.

Stimulant medications, which are adrenergic amines, enhance wakefulness by increasing the levels of norepinephrine and dopamine in the brain. Classic examples include dextroamphetamine, mixed amphetamine salts, and methylphenidate (though methylphenidate is not classified strictly as an adrenergic amine, it acts similarly by increasing catecholaminergic activity). Modafinil and armodafinil, while chemically distinct, also promote wakefulness via adrenergic pathways.

Multiple randomized controlled trials and clinical guidelines (such as those from the American Academy of Sleep Medicine) support the use of adrenergic amine stimulants as first-line or adjunctive therapy for excessive daytime sleepiness in narcolepsy. The efficacy of these agents in improving alertness, reducing sleep attacks, and enhancing quality of life is well documented. However, these medications may have side effects, including increased heart rate, blood pressure, and potential for dependence, so their use is carefully monitored.

In summary, the use of adrenergic amines in narcolepsy is grounded in robust scientific evidence and forms a core part of the therapeutic arsenal for this condition.

More about Adrenergic amines
More about Narcolepsy

Products containing Adrenergic amines

We currently have no products on Vitabase that contain this ingredient.